Resonance Health Ltd has released a press release.
R&D Activities Update and Appendix 3B
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- Response to ASX Price and Volume Query
- Execution of Distribution Agreement with EnvoyAI
- Execution of License Agreement
- FDA Clearance Granted for FerriSmart
- R&D Tax Incentive
Later from Resonance Health
- Resonance Health contracted new clinical trials
- Resonance Health Files Provisional Patent
- New AI Tool for Automated Assessment of Liver Fat
- Resonance Health Partners with Siemens healthineers
- Licencee & Royalty Agreement with 3DR Laboratories
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health